Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sensus Healthcare (SRTS) Invested Capital (2016 - 2026)

Sensus Healthcare has reported Invested Capital over the past 11 years, most recently at $48.1 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 13.84% year-over-year to $48.1 million; the TTM value through Dec 2025 reached $48.1 million, down 13.84%, while the annual FY2025 figure was $48.1 million, 13.84% down from the prior year.
  • Invested Capital for Q4 2025 was $48.1 million at Sensus Healthcare, down from $51.2 million in the prior quarter.
  • Over five years, Invested Capital peaked at $55.8 million in Q4 2024 and troughed at $20.4 million in Q2 2021.
  • A 5-year average of $43.7 million and a median of $47.6 million in 2022 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: fell 16.82% in 2021 and later surged 127.52% in 2022.
  • Year by year, Invested Capital stood at $26.1 million in 2021, then skyrocketed by 84.41% to $48.1 million in 2022, then grew by 1.61% to $48.8 million in 2023, then grew by 14.3% to $55.8 million in 2024, then decreased by 13.84% to $48.1 million in 2025.
  • Business Quant data shows Invested Capital for SRTS at $48.1 million in Q4 2025, $51.2 million in Q3 2025, and $52.1 million in Q2 2025.